APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buclizine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Buclizine Industry Growth and Trends Forecast to 2032

19 December 2025105 pages

Choose your research edition.

Industry ResearchBuclizine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Buclizine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Buclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buclizine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Buclizine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Buclizine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buclizine include Sanofi, Johnson and Johnson, Pfizer, UCB, Stuart Pharmaceuticals, Sinphar, Peili Pharmaceutical, MK Pharma and Meider Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Buclizine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Buclizine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Buclizine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Buclizine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Buclizine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Buclizine Market by Company

Sanofi

Johnson and Johnson

Pfizer

UCB

Stuart Pharmaceuticals

Sinphar

Peili Pharmaceutical

MK Pharma

Meider Pharma

Mankind Pharma

Laboratorios Rocnarf

HUA Shin Chemical Pharmaceutical

Al Pharm

Buclizine Segment by Type

Hospital

Drug Store

Buclizine Segment by Application

Antiallergic Agent

Histamine H₁-Receptor Antagonist

Buclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Buclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hospital Table 2. Major Company of Drug Store Table 3. Global Buclizine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Buclizine Sales by Type (2021-2026) & (K Units) Table 5. Global Buclizine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Buclizine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Buclizine Sales Market Share in Value by Type (2021-2026) Table 8. Global Buclizine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Buclizine Sales by Type (2027-2032) & (K Units) Table 10. Global Buclizine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Buclizine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Buclizine Sales Market Share in Value by Type (2027-2032) Table 13. Global Buclizine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Buclizine Sales by Type (2021-2026) & (K Units) Table 15. North America Buclizine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Buclizine Sales by Type (2021-2026) & (K Units) Table 17. Europe Buclizine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Buclizine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Buclizine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Buclizine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Buclizine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Buclizine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Buclizine Sales by Type (2021-2026) & (US$ Million) Table 24. Buclizine Industry Trends Table 25. Buclizine Industry Drivers Table 26. Buclizine Industry Opportunities and Challenges Table 27. Buclizine Industry Restraints Table 28. Global Buclizine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Buclizine Revenue Market Share by Company (2021-2026) Table 30. Global Buclizine Sales by Company (2021-2026) & (K Units) Table 31. Global Buclizine Sales Share by Company (2021-2026) Table 32. Global Buclizine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Buclizine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Buclizine Major Company Production Sites and Headquarters Table 35. Global Buclizine Company, Product Type & Application Table 36. Global Buclizine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Buclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Buclizine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Buclizine Sales by Region (2021-2026) & (K Units) Table 41. Global Buclizine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Buclizine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Buclizine Sales Market Share in Value by Region (2021-2026) Table 44. Global Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Buclizine Sales by Region (2027-2032) & (K Units) Table 46. Global Buclizine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Buclizine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Buclizine Sales Market Share in Value by Region (2027-2032) Table 49. Global Buclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Buclizine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Buclizine Sales by Application (2021-2026) & (K Units) Table 52. Global Buclizine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Buclizine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Buclizine Sales Market Share in Value by Application (2021-2026) Table 55. Global Buclizine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Buclizine Sales by Application (2027-2032) & (K Units) Table 57. Global Buclizine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Buclizine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Buclizine Sales Market Share in Value by Application (2027-2032) Table 60. Global Buclizine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Buclizine Sales by Application (2021-2026) & (K Units) Table 62. North America Buclizine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Buclizine Sales by Application (2021-2026) & (K Units) Table 64. Europe Buclizine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Buclizine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Buclizine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Buclizine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Buclizine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Buclizine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Buclizine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Buclizine Product Portfolio Table 75. Sanofi Recent Development Table 76. Johnson and Johnson Company Information Table 77. Johnson and Johnson Business Overview Table 78. Johnson and Johnson Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson and Johnson Buclizine Product Portfolio Table 80. Johnson and Johnson Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Buclizine Product Portfolio Table 85. Pfizer Recent Development Table 86. UCB Company Information Table 87. UCB Business Overview Table 88. UCB Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. UCB Buclizine Product Portfolio Table 90. UCB Recent Development Table 91. Stuart Pharmaceuticals Company Information Table 92. Stuart Pharmaceuticals Business Overview Table 93. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Stuart Pharmaceuticals Buclizine Product Portfolio Table 95. Stuart Pharmaceuticals Recent Development Table 96. Sinphar Company Information Table 97. Sinphar Business Overview Table 98. Sinphar Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sinphar Buclizine Product Portfolio Table 100. Sinphar Recent Development Table 101. Peili Pharmaceutical Company Information Table 102. Peili Pharmaceutical Business Overview Table 103. Peili Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Peili Pharmaceutical Buclizine Product Portfolio Table 105. Peili Pharmaceutical Recent Development Table 106. MK Pharma Company Information Table 107. MK Pharma Business Overview Table 108. MK Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. MK Pharma Buclizine Product Portfolio Table 110. MK Pharma Recent Development Table 111. Meider Pharma Company Information Table 112. Meider Pharma Business Overview Table 113. Meider Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Meider Pharma Buclizine Product Portfolio Table 115. Meider Pharma Recent Development Table 116. Mankind Pharma Company Information Table 117. Mankind Pharma Business Overview Table 118. Mankind Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Mankind Pharma Buclizine Product Portfolio Table 120. Mankind Pharma Recent Development Table 121. Laboratorios Rocnarf Company Information Table 122. Laboratorios Rocnarf Business Overview Table 123. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Laboratorios Rocnarf Buclizine Product Portfolio Table 125. Laboratorios Rocnarf Recent Development Table 126. HUA Shin Chemical Pharmaceutical Company Information Table 127. HUA Shin Chemical Pharmaceutical Business Overview Table 128. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio Table 130. HUA Shin Chemical Pharmaceutical Recent Development Table 131. Al Pharm Company Information Table 132. Al Pharm Business Overview Table 133. Al Pharm Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Al Pharm Buclizine Product Portfolio Table 135. Al Pharm Recent Development Table 136. North America Buclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Buclizine Sales by Country (2021-2026) & (K Units) Table 138. North America Buclizine Sales Market Share by Country (2021-2026) Table 139. North America Buclizine Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Buclizine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Buclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Buclizine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Buclizine Market Share by Country (2021-2026) Table 144. North America Buclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Buclizine Market Share Forecast by Country (2027-2032) Table 146. Europe Buclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Buclizine Sales by Country (2021-2026) & (K Units) Table 148. Europe Buclizine Sales Market Share by Country (2021-2026) Table 149. Europe Buclizine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Buclizine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Buclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Buclizine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Buclizine Market Share by Country (2021-2026) Table 154. Europe Buclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Buclizine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Buclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Buclizine Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Buclizine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Buclizine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Buclizine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Buclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Buclizine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Buclizine Market Share by Country (2021-2026) Table 164. Asia-Pacific Buclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Buclizine Market Share Forecast by Country (2027-2032) Table 166. Latin America Buclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Buclizine Sales by Country (2021-2026) & (K Units) Table 168. Latin America Buclizine Sales Market Share by Country (2021-2026) Table 169. Latin America Buclizine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Buclizine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Buclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Buclizine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Buclizine Market Share by Country (2021-2026) Table 174. Latin America Buclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Buclizine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Buclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Buclizine Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Buclizine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Buclizine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Buclizine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Buclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Buclizine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Buclizine Market Share by Country (2021-2026) Table 184. Middle East and Africa Buclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Buclizine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Buclizine Distributors List Table 189. Buclizine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Buclizine Image Figure 2. Global Buclizine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buclizine Market Size (2021-2032) & (US$ Million) Figure 4. Global Buclizine Sales (2021-2032) & (K Units) Figure 5. Hospital Image Figure 6. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 7. Drug Store Image Figure 8. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Buclizine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Buclizine Market Share by Type 2025 VS 2032 Figure 11. North America Buclizine Sales Market Share in Volume by Type in 2025 Figure 12. North America Buclizine Sales Market Share in Value by Type in 2025 Figure 13. Europe Buclizine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Buclizine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Buclizine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Buclizine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Buclizine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Buclizine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Buclizine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Buclizine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Buclizine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Antiallergic Agent Image Figure 24. Global Antiallergic Agent Sales YoY Growth (2021-2032) & (K Units) Figure 25. Histamine H₁-Receptor Antagonist Image Figure 26. Global Histamine H₁-Receptor Antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Buclizine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Buclizine Market Share by Application 2025 VS 2032 Figure 29. North America Buclizine Sales Market Share in Volume by Application in 2025 Figure 30. North America Buclizine Sales Market Share in Value by Application in 2025 Figure 31. Europe Buclizine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Buclizine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Buclizine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Buclizine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Buclizine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Buclizine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Buclizine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Buclizine Sales Market Share in Value by Application in 2025 Figure 39. North America Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Buclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Buclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Buclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Buclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Buclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Buclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Buclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Buclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Buclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Buclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Buclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Buclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Buclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Buclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Buclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Buclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Buclizine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Buclizine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Drug Store
Applications
  • Antiallergic Agent
  • Histamine H₁-Receptor Antagonist
Companies covered
  • Sanofi
  • Johnson and Johnson
  • Pfizer
  • UCB
  • Stuart Pharmaceuticals
  • Sinphar
  • Peili Pharmaceutical
  • MK Pharma
  • Meider Pharma
  • Mankind Pharma
  • Laboratorios Rocnarf
  • HUA Shin Chemical Pharmaceutical
  • Al Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buclizine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Buclizine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Buclizine Market by Type
  6. 1.3.1 Hospital
  7. 1.3.2 Drug Store
  8. 1.4 Global Buclizine Market Size by Type
  9. 1.4.1 Global Buclizine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Buclizine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Buclizine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Buclizine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Buclizine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Buclizine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Buclizine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Buclizine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Buclizine Industry Trends
  2. 2.2 Buclizine Industry Drivers
  3. 2.3 Buclizine Industry Opportunities and Challenges
  4. 2.4 Buclizine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Buclizine Revenue (2021-2026)
  2. 3.2 Global Top Players by Buclizine Sales (2021-2026)
  3. 3.3 Global Top Players by Buclizine Price (2021-2026)
  4. 3.4 Global Buclizine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buclizine Major Company Production Sites & Headquarters
  6. 3.6 Global Buclizine Company, Product Type & Application
  7. 3.7 Global Buclizine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buclizine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buclizine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buclizine Tier 1, Tier 2, and Tier 3
4 Buclizine Regional Status and Outlook
  1. 4.1 Global Buclizine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Buclizine Historic Market Size by Region
  3. 4.2.1 Global Buclizine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Buclizine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Buclizine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Buclizine Forecasted Market Size by Region
  7. 4.3.1 Global Buclizine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Buclizine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Buclizine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Buclizine by Application
  1. 5.1 Buclizine Market by Application
  2. 5.1.1 Antiallergic Agent
  3. 5.1.2 Histamine H₁-Receptor Antagonist
  4. 5.2 Global Buclizine Market Size by Application
  5. 5.2.1 Global Buclizine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Buclizine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Buclizine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Buclizine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Buclizine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Buclizine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Buclizine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Buclizine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Buclizine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson and Johnson
  8. 6.2.1 Johnson and Johnson Company Information
  9. 6.2.2 Johnson and Johnson Business Overview
  10. 6.2.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson and Johnson Buclizine Product Portfolio
  12. 6.2.5 Johnson and Johnson Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Buclizine Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 UCB
  20. 6.4.1 UCB Company Information
  21. 6.4.2 UCB Business Overview
  22. 6.4.3 UCB Buclizine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 UCB Buclizine Product Portfolio
  24. 6.4.5 UCB Recent Developments
  25. 6.5 Stuart Pharmaceuticals
  26. 6.5.1 Stuart Pharmaceuticals Company Information
  27. 6.5.2 Stuart Pharmaceuticals Business Overview
  28. 6.5.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stuart Pharmaceuticals Buclizine Product Portfolio
  30. 6.5.5 Stuart Pharmaceuticals Recent Developments
  31. 6.6 Sinphar
  32. 6.6.1 Sinphar Company Information
  33. 6.6.2 Sinphar Business Overview
  34. 6.6.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinphar Buclizine Product Portfolio
  36. 6.6.5 Sinphar Recent Developments
  37. 6.7 Peili Pharmaceutical
  38. 6.7.1 Peili Pharmaceutical Company Information
  39. 6.7.2 Peili Pharmaceutical Business Overview
  40. 6.7.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Peili Pharmaceutical Buclizine Product Portfolio
  42. 6.7.5 Peili Pharmaceutical Recent Developments
  43. 6.8 MK Pharma
  44. 6.8.1 MK Pharma Company Information
  45. 6.8.2 MK Pharma Business Overview
  46. 6.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MK Pharma Buclizine Product Portfolio
  48. 6.8.5 MK Pharma Recent Developments
  49. 6.9 Meider Pharma
  50. 6.9.1 Meider Pharma Company Information
  51. 6.9.2 Meider Pharma Business Overview
  52. 6.9.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Meider Pharma Buclizine Product Portfolio
  54. 6.9.5 Meider Pharma Recent Developments
  55. 6.10 Mankind Pharma
  56. 6.10.1 Mankind Pharma Company Information
  57. 6.10.2 Mankind Pharma Business Overview
  58. 6.10.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mankind Pharma Buclizine Product Portfolio
  60. 6.10.5 Mankind Pharma Recent Developments
  61. 6.11 Laboratorios Rocnarf
  62. 6.11.1 Laboratorios Rocnarf Company Information
  63. 6.11.2 Laboratorios Rocnarf Business Overview
  64. 6.11.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Laboratorios Rocnarf Buclizine Product Portfolio
  66. 6.11.5 Laboratorios Rocnarf Recent Developments
  67. 6.12 HUA Shin Chemical Pharmaceutical
  68. 6.12.1 HUA Shin Chemical Pharmaceutical Company Information
  69. 6.12.2 HUA Shin Chemical Pharmaceutical Business Overview
  70. 6.12.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
  72. 6.12.5 HUA Shin Chemical Pharmaceutical Recent Developments
  73. 6.13 Al Pharm
  74. 6.13.1 Al Pharm Company Information
  75. 6.13.2 Al Pharm Business Overview
  76. 6.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Al Pharm Buclizine Product Portfolio
  78. 6.13.5 Al Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Buclizine Sales by Country
  2. 7.1.1 North America Buclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Buclizine Sales by Country (2021-2026)
  4. 7.1.3 North America Buclizine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Buclizine Market Size by Country
  6. 7.2.1 North America Buclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Buclizine Market Size by Country (2021-2026)
  8. 7.2.3 North America Buclizine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Buclizine Sales by Country
  2. 8.1.1 Europe Buclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Buclizine Sales by Country (2021-2026)
  4. 8.1.3 Europe Buclizine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Buclizine Market Size by Country
  6. 8.2.1 Europe Buclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Buclizine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Buclizine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Buclizine Sales by Country
  2. 9.1.1 Asia-Pacific Buclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Buclizine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Buclizine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Buclizine Market Size by Country
  6. 9.2.1 Asia-Pacific Buclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Buclizine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Buclizine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Buclizine Sales by Country
  2. 10.1.1 South America Buclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Buclizine Sales by Country (2021-2026)
  4. 10.1.3 South America Buclizine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Buclizine Market Size by Country
  6. 10.2.1 South America Buclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Buclizine Market Size by Country (2021-2026)
  8. 10.2.3 South America Buclizine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Buclizine Sales by Country
  2. 11.1.1 Middle East and Africa Buclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Buclizine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Buclizine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Buclizine Market Size by Country
  6. 11.2.1 Middle East and Africa Buclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Buclizine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Buclizine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Buclizine Value Chain Analysis
  2. 12.1.1 Buclizine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Buclizine Production Mode & Process
  7. 12.2 Buclizine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Buclizine Distributors
  10. 12.2.3 Buclizine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst